Rossari Biotech Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth over the last four quarters indicates strong market demand for products.
Improvement in operating margins showcases effective cost management strategies.
Strong cash flow position enhances the company's ability to invest in growth opportunities.

NEGATIVES

High raw material costs have pressured profit margins, affecting overall profitability.
Increased competition in the manufacturing sector could impact market share.
Fluctuating demand cycles may lead to revenue instability in future quarters.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25
Revenue	410.61	483.47	463.77	472.71	489.65	498.35	512.73	579.56	543.72	586.11
Expenses	352.86	419.90	400.10	409.12	424.76	432.41	447.97	510.07	475.86	514.18
Operating Profit	57.75	63.57	63.67	63.59	64.89	65.94	64.76	69.49	67.85	71.92
Other Income	2.19	1.36	3.50	0.39	0.95	0.72	0.55	1.79	1.20	1.60
Interest	6.32	5.03	4.32	2.52	3.69	3.68	4.94	5.50	5.73	6.09
Depreciation	14.11	15.11	15.09	16.07	15.37	15.16	18.32	18.22	17.75	18.23
Profit Before Tax	39.46	44.81	47.78	45.57	46.99	48.11	42.38	47.71	46.10	49.67
Tax	10.24	11.86	13.39	11.44	12.09	12.78	10.68	13.26	12.50	12.80
Net Profit	29.22	32.95	34.39	34.13	34.90	35.33	31.70	34.44	33.60	36.88
Eps in Rs	5.30	5.97	6.23	6.18	6.32	6.39	5.73	6.22	6.07	6.66